Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
1 hedge funds and large institutions have $45 invested in Vaccinex, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 11 closing their positions.
92% less funds holding
Funds holding: 12 → 1 (-11)
100% less capital invested
Capital invested by funds: $1.14M → $45 (-$1.14M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$61 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$564K |
| 2 |
AC
Armistice Capital
New York
|
-$558K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$11.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$231 |
VCNX Hedge Fund Activity: Q4 2024 in Review
1 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q4 2024, worth a combined $45 — down 100% from $1.14M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of VCNX and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Barclays, adding an estimated $61. The largest seller was Point72 Asset Management, exiting entirely with an estimated $564K sold.
- 1 institutional investor held Vaccinex, Inc. Common Stock (VCNX) as of Q4 2024, down from 12 in Q3 2024.
- Funds reported $45 of Vaccinex, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new Vaccinex, Inc. Common Stock positions in Q4 2024 and 11 closed out, a net change of -11 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q4 2024 was Barclays, an estimated $61 added.
- The largest Vaccinex, Inc. Common Stock seller in Q4 2024 was Point72 Asset Management, an estimated $564K sold.
Based on aggregated 13F filings for Q4 2024.